3Kao SJ,You I,Clewell DB,et al.Detection of the high-level aminoglycoside resistance gene aph(2")-Ⅰb in enterococcus faecium.Antimicrob Agents Chemother,2000,44(10):2876-2879.
4Chow JW,Lerner SA,Zervos MJ,et al.Multiples PCR for detection of aminoglycoside resistance genes in enterococci.Antimicrob Agents Chemother,2003,47(4):1423-1426.
5Fines M,Perichon B,Reynolds P,et al.VanE,a new type of acquired glycopeptide resistance in enterococcus faecalis BM4405.Antimicrob Agents Chemother,1999,43(9):2161-2164.
6Leclercq R,Courvalin P.Resistance to glycopeptides in enterococci.Clin Infect Dis,1997,24(4):545-556.
8Handwerger S,Skoble J.Identification of chromosomal mobile element conferring high-level vancomycin resistance in enterococcus faecium.Antimicrob Agents Chemother,1995,39( 11 ):2446-2453.
9Clark NC,Teixeira LM,Facklam RR,et al.Detection and differentiation of vanC-1,vanC-2,and vanC-3 glycopeptide resistance genes in enterococci.J Clin Microbiol,1998,36(8):2294-2297.
10Lafaurie M,Perichon B,Lefort A,et al.Consequences of VanE-type resistance on efficacy of glycopeptides in vitro and in experimental endocarditis due to enterococcus faecalis.Antimicrob Agents Chemother,2001,45 (10):2826-2830.
二级参考文献68
1[1]Pechere JC, Streptogramins, a unique class of antibiotics. Drugs,1996; 51 (Suppl1): S20.
3[3]Lamb HM,Figgitt DP, Faulds D. Quinupristin-dalfopristin. A review of its use in the management of serious gram-positive infections. Drugs, 1999; 58: 1061.
4[4]Barriere JC, Berthaud N. Recent developments in streptogramin research. Curr, Pharm Des, 1998; 4: 155.
5[5]Chu DTW. Recent progress in novel macrolides, quinolones and 2-pyridones to overcome bacterial resistance. Med Res Rev,1999, 19: 497.
6[6]Bricker S J, Hutchinson DK, Barbachyn MR, et al. Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant Gram- positive bacterial infections. J Med Chem, 1996; 39: 673.
7[7]Barbachyn MR, Hutchinson DK, Bricker SJ, et al. Identification of a novel oxazolidinoe (U-100480) with potant antimycoba cterial activity J Med Chem, 1996; 39: 680.
8[8]Clemett D, Markham A. Linezolide, Drugs,2000;59:815.
9[10]Gadwood RC, Shinabarger DA. Progress in the oxazolidinone antibacterials . Annu Rep Med Chem, 2000; 35: 135.
10[11]New agents presented at interscience conference on antimicrobial agents and chemotherapy (ICAAC). Scrip, 2002;No. 2710: 23,
